CU23102A1 - Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos - Google Patents

Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos

Info

Publication number
CU23102A1
CU23102A1 CU20020235A CU20020235A CU23102A1 CU 23102 A1 CU23102 A1 CU 23102A1 CU 20020235 A CU20020235 A CU 20020235A CU 20020235 A CU20020235 A CU 20020235A CU 23102 A1 CU23102 A1 CU 23102A1
Authority
CU
Cuba
Prior art keywords
proteins
production
mammary gland
recombinant proteins
transgenic mammals
Prior art date
Application number
CU20020235A
Other languages
English (en)
Inventor
Ramos Oliberto Sanchez
Alonso Jorge Roberto Toledo
Molto Maria Pilar Rodriguez
Reboredo Fidel Ovidio Castro
Original Assignee
Ct Ingenieria Genetica Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech
Priority to CU20020235A priority Critical patent/CU23102A1/es
Priority to ARP030103775A priority patent/AR041644A1/es
Priority to AU2003273726A priority patent/AU2003273726B8/en
Priority to RU2005115495/13A priority patent/RU2345088C2/ru
Priority to BR0315555-2A priority patent/BR0315555A/pt
Priority to KR1020057006830A priority patent/KR20050083791A/ko
Priority to PCT/CU2003/000011 priority patent/WO2004034780A2/es
Priority to CA002502902A priority patent/CA2502902A1/en
Priority to CNA2003801034448A priority patent/CN1744814A/zh
Priority to JP2004543918A priority patent/JP2006503560A/ja
Priority to EP03757653A priority patent/EP1557084A2/en
Priority to MXPA05004295A priority patent/MXPA05004295A/es
Priority to ZA200503166A priority patent/ZA200503166B/en
Publication of CU23102A1 publication Critical patent/CU23102A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/102—Caprine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Método que permite la producción de proteínas de interés bio-farmacéutico a partir de la glándula mamaria de animales no transgénicos. Los genes que codifican para dichas proteínas son transferidos a las células epiteliales mamarias empleando vectores adenovirales. Tales vectores pueden estar basados en adenovirus con replicación defectiva como el ?E1?E3. o en adenovirus dependientes de ayudantes a los cuales se les han eliminado todas o casi todas la secuencias adenovirales codificantes. Mediante este método es posible la producción altos niveles de proteínas recombinantes en la leche permitiendo de esta forma la producción a gran escala de proteínas de interés biofarmacéutico en su forma biológicamente activa.
CU20020235A 2002-10-21 2002-10-21 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos CU23102A1 (es)

Priority Applications (13)

Application Number Priority Date Filing Date Title
CU20020235A CU23102A1 (es) 2002-10-21 2002-10-21 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos
ARP030103775A AR041644A1 (es) 2002-10-21 2003-10-16 Metodo para la produccion de proteinas recombinantes en la glandula mamaria de mamiferos no transgenicos
AU2003273726A AU2003273726B8 (en) 2002-10-21 2003-10-20 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals
RU2005115495/13A RU2345088C2 (ru) 2002-10-21 2003-10-20 Способ получения рекомбинантных белков в молочной железе нетрансгенных млекопитающих
BR0315555-2A BR0315555A (pt) 2002-10-21 2003-10-20 Método para a produção de proteìnas heterólogas no leite de mamìferos não humanos mediante a transformação do egm com vetores adenovirais
KR1020057006830A KR20050083791A (ko) 2002-10-21 2003-10-20 비-유전자도입 포유동물의 유선에서 재조합 단백질의생산방법
PCT/CU2003/000011 WO2004034780A2 (es) 2002-10-21 2003-10-20 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos
CA002502902A CA2502902A1 (en) 2002-10-21 2003-10-20 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals
CNA2003801034448A CN1744814A (zh) 2002-10-21 2003-10-20 从非转基因哺乳动物乳腺生产重组蛋白质的方法
JP2004543918A JP2006503560A (ja) 2002-10-21 2003-10-20 非形質転換哺乳動物の乳腺における組換えタンパク質の製造法
EP03757653A EP1557084A2 (en) 2002-10-21 2003-10-20 Method of producing recombinant proteins in the mammary gland of non-transgenic mammals
MXPA05004295A MXPA05004295A (es) 2002-10-21 2003-10-20 Metodo para la produccion de proteinas recombinantes en la glandula mamaria de mamiferos no transgenicos.
ZA200503166A ZA200503166B (en) 2002-10-21 2005-04-19 Method of producing recombinant proteins in the mammary gland on non-transgenic mammals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20020235A CU23102A1 (es) 2002-10-21 2002-10-21 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos

Publications (1)

Publication Number Publication Date
CU23102A1 true CU23102A1 (es) 2005-12-20

Family

ID=40134844

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20020235A CU23102A1 (es) 2002-10-21 2002-10-21 Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos

Country Status (13)

Country Link
EP (1) EP1557084A2 (es)
JP (1) JP2006503560A (es)
KR (1) KR20050083791A (es)
CN (1) CN1744814A (es)
AR (1) AR041644A1 (es)
AU (1) AU2003273726B8 (es)
BR (1) BR0315555A (es)
CA (1) CA2502902A1 (es)
CU (1) CU23102A1 (es)
MX (1) MXPA05004295A (es)
RU (1) RU2345088C2 (es)
WO (1) WO2004034780A2 (es)
ZA (1) ZA200503166B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU23576A1 (es) * 2006-02-28 2010-09-30 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la influenza aviar
CU23544A1 (es) * 2006-02-28 2010-06-17 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
CN1869217B (zh) * 2006-05-22 2013-08-07 李青旺 以腺病毒为载体乳腺表达生产转基因蛋白药物的方法
CN102124109B (zh) * 2008-06-30 2013-10-16 Cho-A制药有限公司 猪α-S1-酪蛋白基因，其启动子及其用途
EP2793936A4 (en) * 2011-12-19 2015-05-27 Lfb Usa Inc RECOMBINANT HUMAN ALPHA-1-ANTITRYPINE FOR THE TREATMENT OF INFLAMMATORY DISEASES
CL2014002410A1 (es) * 2014-09-12 2014-11-14 Univ Concepcion Método para la producción de proteínas recombinantes en glándula mamaria de mamíferos mediante la transformación del epítelio glandular mamario con vectores adenoasociados.
WO2018085967A1 (en) * 2016-11-08 2018-05-17 Guangzhou Institutes Of Biomedicine And Health, Chinese Academy Of Sciences Genetically humanized mammals expressing human serum albumin and uses thereof
WO2021013997A1 (en) 2019-07-25 2021-01-28 Medichem, S.A. Process for the synthesis of n-alkyl-4-pyridinamines
WO2025252759A1 (en) 2024-06-03 2025-12-11 Bio-Sourcing Transient expression by lipid nanoparticle formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780009A (en) * 1995-01-20 1998-07-14 Nexia Biotechnologies, Inc. Direct gene transfer into the ruminant mammary gland
AU7719596A (en) * 1995-11-07 1997-05-29 Baylor College Of Medicine Adenovirus-mediated production of bioactive proteins by mammalian cells and animals
EP0954579A1 (en) * 1996-06-20 1999-11-10 Merck & Co., Inc. Gene therapy for obesity
AU753907B2 (en) * 1998-02-24 2002-10-31 Her Majesty In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada Trans-somatics with gene transfer into mammary epithelial cells
WO2002034282A2 (en) * 2000-10-27 2002-05-02 Beth Israel Deaconess Medical Center, Inc. Mammary secreted protein 36 (msp36) for cancer treatment and diagnosis

Also Published As

Publication number Publication date
WO2004034780A2 (es) 2004-04-29
AU2003273726B8 (en) 2009-09-03
AU2003273726B2 (en) 2009-07-09
MXPA05004295A (es) 2005-08-03
AR041644A1 (es) 2005-05-26
RU2345088C2 (ru) 2009-01-27
RU2005115495A (ru) 2005-11-20
KR20050083791A (ko) 2005-08-26
JP2006503560A (ja) 2006-02-02
EP1557084A2 (en) 2005-07-27
ZA200503166B (en) 2006-10-25
WO2004034780A3 (es) 2004-05-27
CA2502902A1 (en) 2004-04-29
BR0315555A (pt) 2005-08-23
AU2003273726A1 (en) 2004-05-04
CN1744814A (zh) 2006-03-08

Similar Documents

Publication Publication Date Title
Santos et al. Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene delivery vectors
Wassarman et al. Zona pellucida genes and proteins: essential players in mammalian oogenesis and fertility
Ding et al. Plastin increases cortical connectivity to facilitate robust polarization and timely cytokinesis
CU23102A1 (es) Método para la producción de proteínas recombinantes en la glándula mamaria de mamíferos no transgénicos
Massoulié et al. The C-terminal peptides of acetylcholinesterase: cellular trafficking, oligomerization and functional anchoring
Aranjuez et al. Dynamic myosin activation promotes collective morphology and migration by locally balancing oppositional forces from surrounding tissue
PE20221770A1 (es) Composiciones de proteina anti-vegf y metodos para producir la misma
Ciska et al. NMCP/LINC proteins: putative lamin analogs in plants?
Sharp et al. Roles of motor proteins in building microtubule-based structures: a basic principle of cellular design
AR080229A1 (es) Proteinas de dominio de armazon de fibronectina que se unen a il -23 (interleucina 23)
PE20240371A1 (es) Metodos escalables para producir un vector viral adenoasociado (aav) recombinante en un sistema de cultivo celular en suspension sin suero adecuado para uso clinico
CU24483B1 (es) Método para incrementar los niveles de secreción de la interleucina-2
ES2531135T3 (es) Fitasas, ácidos nucleicos que las codifican y métodos para su producción y uso
ATE454455T1 (de) Leitsequenzen zur anleitung von polypeptidsekretion und verfahren zur herstellung
AR049214A1 (es) Peptidos de transito a plastidos
MX384304B (es) Polipéptidos y polinucleótidos aislados y métodos para su uso, para aumentar el rendimiento, la biomasa, el índice de crecimiento, el vigor, el contenido de aceite, la tolerancia al estrés abiótico de las plantas y la eficiencia en el uso de nitrógeno.
AR049177A1 (es) Polipeptidos y conjugados de interferon-alfa
Wilson et al. Evolution of the multi‐tubulin hypothesis
AR066380A1 (es) Metodo para incrementar el rendimiento en plantas en condiciones de disponibilidad reducida de nutrientes y un metodo para desarrollarlas
CO6300796A2 (es) Proceso para la produccion de proteina exogena en la leche de mamifero transgenico
CY1118782T1 (el) Επιλογη κυτταρων που εκφραζουν ετερομερη πολυπεπτιδια
Szikora et al. The mechanisms of thin filament assembly and length regulation in muscles
Sahoo et al. Characterization of calumenin in mouse heart.
AR026571A1 (es) Genes del musgo de la physcomitrella patens que codifican proteinas que participan en la sintesis de los acidos grasos poliinsaturados y lipidos
Arora et al. Flightless I interacts with NMMIIA to promote cell extension formation, which enables collagen remodeling